Why the study?
Flow cytometry with ADP allows characterization of platelet function, but the methodology had not been thoroughly investigated, standardized, or characterized.
Does a standardized flow cytometry protocol with ADP stimulation accurately assess platelet functional activity in healthy individuals, post-PCI patients on DAPT, and ITP patients?
Does a standardized flow cytometry protocol with ADP stimulation accurately assess platelet functional activity in healthy individuals, post-PCI patients on DAPT, and ITP patients?
A standardized flow cytometry protocol using ADP stimulation provides a sensitive and physiological assessment of platelet function, useful for monitoring antiplatelet therapy and platelet disorders.
Optimal ADP flow cytometry conditions identified; leaves open multicenter validation for platelet testing.
OBJECTIVES: Flow cytometry with adenosine diphosphate (ADP) allows to characterize molecular changes of platelet function caused by this physiologically important activation, but the methodology has not been thoroughly investigated, standardized and characterized yet. We analyzed the influence of several major variables and chose optimal conditions for platelet function assessment. METHODS: , 5 μM ADP and antibodies were added to diluted blood and incubated for 15 min. We analyzed kinetics of antibody binding and effects of their addition sequence, agonist concentration, blood dilution, exogenous calcium addition and platelet fixation. RESULTS: We tested our protocol on 11 healthy children, 22 healthy adult volunteers, 9 patients after a month on dual antiplatelet therapy after percutaneous coronary intervention (PCI), 7 adult patients and 14 children with immune thrombocytopenia (ITP). We found that our protocol is highly sensitive to ADP stimulation with low percentage of aggregates formation. The assay is also sensitive to platelet function inhibition in post-PCI patients. Finally, platelet preactivation with ITP plasma was stronger and caused increase in activation response to ADP stimulation compared to preactivation with low dose of ADP. CONCLUSIONS: Our assay is sensitive to antiplatelet therapy and platelet preactivation in ITP patients under physiological conditions with minimal percentage of aggregates formation.
No takes yet. Share an insight, caveat, or question.
Ponomarenko et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: